Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The impact of genomics on the exploitation of the myxobacterial secondary metabolome.
Wenzel SC, Müller R. Wenzel SC, et al. Nat Prod Rep. 2009 Nov;26(11):1385-407. doi: 10.1039/b817073h. Epub 2009 Jul 28. Nat Prod Rep. 2009. PMID: 19844638 Review. No abstract available.
From genetic diversity to metabolic unity: studies on the biosynthesis of aurafurones and aurafuron-like structures in myxobacteria and streptomycetes.
Frank B, Wenzel SC, Bode HB, Scharfe M, Blöcker H, Müller R. Frank B, et al. J Mol Biol. 2007 Nov 16;374(1):24-38. doi: 10.1016/j.jmb.2007.09.015. Epub 2007 Sep 11. J Mol Biol. 2007. PMID: 17919655
Novel polyene carboxylic acids from Streptomyces.
Wenzel SC, Bode HB. Wenzel SC, et al. J Nat Prod. 2004 Sep;67(9):1631-3. doi: 10.1021/np049852t. J Nat Prod. 2004. PMID: 15387680
Heterologous production of myxobacterial α-pyrone antibiotics in Myxococcus xanthus.
Sucipto H, Pogorevc D, Luxenburger E, Wenzel SC, Müller R. Sucipto H, et al. Metab Eng. 2017 Nov;44:160-170. doi: 10.1016/j.ymben.2017.10.004. Epub 2017 Oct 10. Metab Eng. 2017. PMID: 29030273
Modular construction of a functional artificial epothilone polyketide pathway.
Osswald C, Zipf G, Schmidt G, Maier J, Bernauer HS, Müller R, Wenzel SC. Osswald C, et al. ACS Synth Biol. 2014 Oct 17;3(10):759-72. doi: 10.1021/sb300080t. Epub 2012 Nov 5. ACS Synth Biol. 2014. PMID: 23654254
The biosynthetic potential of myxobacteria and their impact in drug discovery.
Wenzel SC, Müller R. Wenzel SC, et al. Curr Opin Drug Discov Devel. 2009 Mar;12(2):220-30. Curr Opin Drug Discov Devel. 2009. PMID: 19333867 Review.
52 results
Jump to page
Feedback